New York, USA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Market Overview:
The global cellular starting materials market was estimated at USD 1.43 billion in 2023, and it is expected to reach USD 9.00 billion by 2032, with a compound annual growth rate (CAGR) of 22.8% during the forecast period (2024 - 2032).
What are Cellular Starting Materials?
During the development of cell therapies, cellular starting materials are used to ensure their quality, safety, and efficacy. Extracted from various sources, starting materials like stem cells, primary cells, and cell lines play a critical role in the making of advanced therapies and regenerative medicine.
It is essential to properly handle, process, and maintain the integrity of these starting materials until the final result is achieved. Cellular Starting Materials function as a crucial component for producing therapeutic products designed to address diseases and disorders at the cellular level. Also, they can repair or replace damaged tissues and generate new tissues for medical use.
Download Free Sample PDF Copy of the Report:
Key Market Stats:
- Global cellular starting materials market size was valued at USD 1.43 billion in 2023.
- The industry is anticipated to expand from USD 1.74 billion in 2024 to USD 9.00 billion by 2032.
- According to the projection, the market will generate a compound annual growth rate (CAGR) of 22.8% during the forecast period (2024 - 2032).
Major Findings From the Report:
- The market for cellular starting materials is anticipated to rise as a result of a number of factors, including the rising incidence of chronic diseases, such as cancer, diabetes, and autoimmune disorders; increased investments; growing demand for cell and gene-based therapies; and technical advancements.
- The market is segmented based on product, grade, end-use, and region.
- The North America region had the highest cellular starting materials market share in the market.
Request for a Discount on this Report Before Purchase:
Market Drivers and Trends:
- Rising Demand for Biopharmaceuticals: A number of illnesses, such as cancer, autoimmune disorders, and infectious diseases, can be treated with biopharmaceuticals like monoclonal antibodies and vaccines as a crucial component. CSMs are important and required as key raw materials during the development process of Biopharmaceuticals. Thus, increasing demand for these biopharmaceuticals fuels the market growth.
- Increased Demand For High-Quality CSMs for Manufacturing: Biopharmaceutical applications are expanding owing to the developments in biotechnology and immunotherapy, leading to the surging demand for high-quality CSMs for manufacturing. This factor propels the cellular starting materials market CAGR.
- Shifts Towards Personalized Medicine: The healthcare sector is majorly leveraging personalized medicine that promises improved treatment outcomes, reduced adverse effects, and precise therapies. Cellular starting materials (CSMs) have a key role in each therapy of Personalized medicine that involves cell-based treatments, gene therapies, and personalized vaccines. Thus, the rising shift towards personalized medicine drives the cellular starting materials market demand.
- Large Investment In Technologies And Commercialization of Personalized Therapies: A number of biopharmaceutical firms and research institutions are generating funds to develop advanced infrastructure to augment CSMs’ production and quality assurance processes. Additionally, Regulatory agencies favor the development and commercialization of personalized therapies, which is boosting the market growth.
Industry’s Prominent Players:
- AcceGen
- AllCells
- Anthony Nolan
- BioIVT
- CGT GLOBAL
- Charles River Laboratories
- Excellos
- HumanCells Bio
- NMDP BioTherapies.
- STEMCELL Technologies
Geographical Landscape:
On the basis of geography, the global cellular starting materials market in North America held the greatest revenue share due to the rise in the usage of advanced biotechnology in regenerative medicine and drug invention. Increased R&D activities and the presence of a well-developed infrastructure are the primary contributors to the regional market demand. Also, collaborations are happening among main academic institutions and biotech firms to introduce novel technologies that bolster industry growth.
The market is projected to experience the fastest growth in Asia Pacific, with the highest CAGR rate during the anticipated period. Growing investments in biotechnology, evolving healthcare infrastructure, and the growing occurrence of chronic diseases are responsible for the market’s development in the region. Nations such as China, Japan, South Korea, and India have been leading market players, enlarging their research and development efforts in regenerative medicine and cell-based therapies.
Inquire more about this report before purchase:
Market Segmentation:
Cellular Starting Materials Product Outlook
- Leukopaks
- Cells & Tissues
Cellular Starting Materials Grade Outlook
- GMP
- Research-use
Cellular Starting Materials End-Use Outlook
- Pharmaceutical & Biotechnology Companies
- CMOs & CROs
- Academic & Research Institutes
Cellular Starting Materials Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia-Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Browse More Research Reports:
Surgical Suction Instruments Market
U.S. Viral Vector And Plasmid DNA Manufacturing Market
About Polaris Market Research:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Contact:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
